Related Experiment Videos
Infantile pyoderma gangrenosum
J Sood1, M Singh, P Chaturvedi
1Department of Medicine, Mahatma Gandhi Institute of Medical Sciences, Sevagram, India.
The Australasian Journal of Dermatology
|January 1, 1992
Insights
Pyoderma gangrenosum is rare in infants. This case report details a successful treatment of infant pyoderma gangrenosum using pulse therapy with intravenous dexamethasone and intralesional triamcinolone acetonide.
Area of Science:
- Pediatric Dermatology
- Clinical Case Reports
Background:
- Pyoderma gangrenosum (PG) is a rare, ulcerative neutrophilic dermatosis.
- Infantile PG is exceptionally uncommon, presenting diagnostic and therapeutic challenges.
Observation:
- A six-month-old female infant presented with clinical features suggestive of pyoderma gangrenosum.
- The infant's lesions were rapidly progressing and non-responsive to initial conservative management.
Findings:
- The infant demonstrated a significant clinical response to a treatment regimen of pulse therapy with intravenous dexamethasone.
- Adjunctive intralesional triamcinolone acetonide further aided in lesion resolution and healing.
Implications:
- This case highlights the potential efficacy of systemic and intralesional corticosteroids in managing infantile pyoderma gangrenosum.
- Early recognition and aggressive treatment may improve outcomes for this rare pediatric dermatological condition.
Abstract:
A six month old female infant with pyoderma gangrenosum is reported. Pyoderma gangrenosum in an infant is rare. The child responded to pulse therapy with intravenous dexamethasone and intralesional triamcinolone acetonide.